TOKYO -- Fujitsu has teamed up with the government-backed Riken research institute to develop generative AI technology that predicts the state of a drug's target protein in the body more than 10 times as fast as existing methods.
Technology
Fujitsu taps generative AI to help speed drug development
Technology predicts state of target protein 10 times as fast
Fujitsu's and Riken's generative AI technology reproduces proteins in 3D and helps predict their movements. (Image obtained by Nikkei)
Read Next
Latest on Technology
